Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 4, 2005, Pages 392-397

  Golub, Jonathan E ^a,b,c   Bur, S ^b   Cronin, W A ^b   Gange, S ^c   Sterling, T R ^a   Oden, B ^b   Baruch, N ^b   Comstock, G W ^c   Chaisson, R E ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Tuberculosis Control   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antibiotics; Community acquired pneumonia; Delayed diagnosis; Tuberculosis

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLINDAMYCIN; COTRIMOXAZOLE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC VALUE; DRUG INDICATION; FEMALE; HEALTH CARE DELIVERY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; THORAX RADIOGRAPHY;

ADULT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; RADIOGRAPHY, THORACIC; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 17144422842     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med 2001; 163: 1730-1754.
2. Barrlett J G, Dowell S F, Mandell L A, File T M, Musher D M, Fine M J. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31: 347-382.
3. Harries A D, Banda H T, Boeree M J, et al. Management of pulmonary tuberculosis suspects with negative sputum smears and normal or minimally abnormal chest radiographs in resource-poor settings. Int J Tuberc Lung Dis 1998; 2: 999-1004.
4. Banda H T, Harries A D, Welby S, et al. Prevalence of tuberculosis in TB suspects with short duration of cough. Trans R Soc Trop Med Hyg 1998; 92: 161-163.
5. Thadepalli H, Rambhatia K, Niden A H. Transtracheal aspiration in diagnosis of sputum-smear-negative tuberculosis. JAMA 1977; 238: 1037-1040.
6. Wilkinson D, Newman W, Reid A, Squire S B, Sturm A W, Gilks C F. Trial-of-antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a developing country with high HIV prevalence. Int J Tuberc Lung Dis 2000; 4: 513-518.
7. Dooley K E, Golub J E, Goes F S, Merz W G, Sterling T R. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis. Clin Infect Dis 2002; 34: 1607-1612.
8. Mathur P, Sacks L, Auten G, Sall R, Levy C, Gordin F. Delayed diagnosis of pulmonary tuberculosis in city hospitals. Arch Intern Med 1994; 154: 306-310.
9. Pablos-Mendez A, Sterling T R, Frieden T R. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 1996; 276: 1223-1228.
10. Campbell I G. Miliary tuberculosis in British Columbia. Can Med Assoc J 1973; 108: 1517-1519.
11. Bobrowitz I D. Active tuberculosis undiagnosed until autopsy. Am J Med 1982; 72: 650-658.
12. Kramer F, Modilevsky T, Waliany A R, Leedom J M, Barnes P F. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med 1990; 89: 451-456.
13. Enarson D A, Grzybowski S, Dorken E. Failure of diagnosis as a factor in tuberculosis mortality. Can Med Assoc J 1978;118: 1520-1522.
14. Golub J E, Cronin W A, Obasanjo O O, et al. Transmission of Mycobacterium tuberculosis through casual contact with an infectious case. Arch Intern Med 2001; 161: 2254-2258.
15. Kantor H S, Poblete R, Pusateri S L. Nosocomial transmission of tuberculosis from unsuspected disease. Am J Med 1988; 84: 833-838.
16. MacIntyre C R, Plant A J, Hulls J, Streeton J A, Graham N M, Rouch G J. High rate of transmission of tuberculosis in an office: impact of delayed diagnosis. Clin Infect Dis 1995; 21: 1170-1174.
17. Davies S, Sparham P D, Spencer R C. Comparative in-vitro activity of five fluoroquinolones against mycobacteria. J Antimicrob Chemother 1987; 19: 605-609.
18. Berlin O G, Young L S, Bruckner D A. In vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis. J Antimicrob Chemother 1987; 19: 611-615.
19. Yew W W, Piddock L J, Li M S, Lyon D, Chan C Y, Cheng A F. In-vitro activity of quinolones and macrolides against mycobacteria. J Antimicrob Chemother 1994; 34: 343-351.
20. Craig S E, Springett J, Sabin C A, et al. Think TB! Is the diagnosis of pulmonary tuberculosis delayed by antibacterial treatment? Am J Respir Crit Care Med 2002; 165, A714. [Abstract]
21. KiaNoury D, Timpone J, Yeager H Jr. Can administration of a fluoroquinolone delay diagnosis of pulmonary tuberculosis? Int J Tuberc Lung Dis 2000; 4: 1092.